Frost & Sullivan, March 2009, Pages: 58
strategic analysis of the European specialtypharmamarket and includes an introduction, market overview, market engineering research, competitor analysis, global therapeutic-area wise opportunity analysis
JZMed Inc, Oct 2011, Pages: 215
Figure 6. Analysis of current global demands for biopharma outsourcing service
Figure 7. Past growth trend of globalpharma outsourcing market
Figure 8. Past growth trend of outsourcing proportion in major
Global Industry Analysts, Inc., Jan 2012, Pages: 443
2015 4
Oncologics - The Largest Drug Class in the Global Prescription
Pharmaceutical Market 5
Table 3: World Recent Past, Current & Future Analysis for
Prescription Pharmaceuticals by Therapeutic
Espicom Business Intelligence Ltd, May 2010
as doctors by specialty, nursing staff and dentists
ACCESSING THE PHARMAMARKET
- Regulatory environment
- Distribution guide and trade fair information
- Domestic production
CONTACT DETAILS
Global Industry Analysts, Inc., Sep 2011, Pages: 611
79
B.Market Analytics 82
Table 48: US Recent Past, Current & Future Analysis for
Medical Specialty Bags by Product Segment
GlobalData, Feb 2012, Pages: 28
Product Sales Of $85.9m For Q1 Fiscal 2011
GlobalData’s Aptalis Pharma Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business
GBI Research, Aug 2010, Pages: 71
contract sales outsourcing market
- Make more informed business decisions from the insightful and in-depth analysis of the global contract sales outsourcing market and the factors shaping it “Pharmaceutical
GlobalData, Sep 2011, Pages: 34
comprehensive SWOT profile of Alliance Pharma Plc provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear
Business Insights, Jan 2004, Pages: 150
: Drivers of sustainable development within the biotech, specialty and major pharma sectors’, provides the timely analysis senior executives need to maximize business opportunities in 2004. This report
JZMed Inc, May 2011, Pages: 230
protection
Table 22. Top five major pharma companies in emerging markets (their current sales revenue made from the emerging markets and the proportion in their total global sales revenue)
Table 23. Market
Business Review, Sep 2010, Pages: 23
Bayer Schering Pharma AG: SWOT Analysis & Company Profile Synopsis
Business Review’s Bayer Schering Pharma AG contains a company overview, key facts, locations and subsidiaries, news and events as
Global Industry Analysts, Inc., Jan 2011, Pages: 266
and forecasts are provided for the period 2009 through 2015. Also, a six-year historic analysis is provided for this market. The report profiles 85 companies including many key and niche players such as
Spectra Intelligence, Nov 2011, Pages: 66
interest for major pharmaceutical companies, reflecting the view that orphan drugs were specialty products with limited market potential thus offering a poor fit for companies based upon the blockbuster
